Detalhe da pesquisa
1.
The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection.
Int J Mol Sci
; 23(11)2022 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35682757
2.
Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.
Pharmacol Res
; 121: 194-201, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495657
3.
Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi.
BMC Immunol
; 14 Suppl 1: S10, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23458379
4.
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.
BMC Immunol
; 14 Suppl 1: S4, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23458578
5.
Mucosal and systemic immune responses following mucosal immunisation of tetanus toxoid entrapped in lipid nanoparticles prepared by microwave reactor.
Eur J Pharm Biopharm
; 171: 11-18, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990784
6.
AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses.
Scand J Infect Dis
; 43(10): 809-13, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21671827
7.
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.
Methods
; 49(4): 301-8, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19410000
8.
Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice.
Methods
; 49(4): 309-15, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19545630
9.
Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines.
Methods Mol Biol
; 1969: 181-203, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30877678
10.
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.
PLoS One
; 14(8): e0221708, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442285
11.
Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats.
Pharmaceutics
; 11(12)2019 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31771151
12.
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.
Expert Rev Vaccines
; 18(1): 15-30, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526162
13.
Second international congress on immunopharmacology: delivery systems and current strategies for drug design.
BMC Immunol
; 14 Suppl 1: S1, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23458346
14.
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1).
Heliyon
; 2(8): e00147, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622215
15.
Bacterial outer membrane vesicles and vaccine applications.
Front Immunol
; 5: 121, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24715891
16.
Optimizing efficacy of mucosal vaccines.
Expert Rev Vaccines
; 11(9): 1139-55, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23151169
17.
Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisation.
PLoS One
; 7(10): e46461, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23077508
18.
Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Expert Rev Vaccines
; 8(1): 103-12, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19093777
19.
A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice.
Vaccine
; 27(2): 205-12, 2009 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18996426
20.
The adjuvant potential of synthetic alkylglycerols.
Vaccine
; 24 Suppl 2: S2-32-3, 2006 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-16823915